If IBD flares during chemotherapy, corticosteroids are first-line therapy, with vedolizumab or ustekinumab as second-line options; accumulating evidence also supports cautious anti-TNF use [94,112]. The gene discussed is TNF; the disease is inflammatory bowel disease.